BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36521546)

  • 1. Deleterious effects of cardiomyocyte-specific prostaglandin E2 EP3 receptor overexpression on cardiac function after myocardial infarction.
    Maxwell DL; Bryson TD; Taube D; Xu J; Peterson E; Harding P
    Life Sci; 2023 Jan; 313():121277. PubMed ID: 36521546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Gene Deletion or Antagonism of the Prostaglandin E2 EP3 Receptor Protects Against Cardiac Injury Postmyocardial Infarction.
    Bryson TD; Bhat SY; Moore C; Taube D; Xu J; Peterson E; Harding P
    Circ Heart Fail; 2024 Apr; 17(4):e011089. PubMed ID: 38525608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of prostaglandin E2 EP4 receptor improves cardiac function after myocardial infarction.
    Bryson TD; Gu X; Khalil RM; Khan S; Zhu L; Xu J; Peterson E; Yang XP; Harding P
    J Mol Cell Cardiol; 2018 May; 118():1-12. PubMed ID: 29522761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deleterious role of the prostaglandin E
    Bryson TD; Pandrangi TS; Khan SZ; Xu J; Pavlov TS; Ortiz PA; Peterson E; Harding P
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H867-H882. PubMed ID: 32142358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
    Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
    Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological modulation of prostaglandin E
    Bosma KJ; Ghosh M; Andrei SR; Zhong L; Dunn JC; Ricciardi VF; Burkett JB; Hatzopoulos AK; Damron DS; Gannon M
    Physiol Rep; 2022 Apr; 10(7):e15212. PubMed ID: 35403369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction.
    Tang J; Shen Y; Chen G; Wan Q; Wang K; Zhang J; Qin J; Liu G; Zuo S; Tao B; Yu Y; Wang J; Lazarus M; Yu Y
    Nat Commun; 2017 Mar; 8():14656. PubMed ID: 28256515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced cardiac remodeling and function in cardiac-specific EP4 receptor knockout mice with myocardial infarction.
    Qian JY; Harding P; Liu Y; Shesely E; Yang XP; LaPointe MC
    Hypertension; 2008 Feb; 51(2):560-6. PubMed ID: 18180401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury.
    Martin M; Meyer-Kirchrath J; Kaber G; Jacoby C; Flögel U; Schrader J; Rüther U; Schrör K; Hohlfeld T
    Circulation; 2005 Jul; 112(3):400-6. PubMed ID: 16009796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte-specific overexpression of oestrogen receptor β improves survival and cardiac function after myocardial infarction in female and male mice.
    Schuster I; Mahmoodzadeh S; Dworatzek E; Jaisser F; Messaoudi S; Morano I; Regitz-Zagrosek V
    Clin Sci (Lond); 2016 Mar; 130(5):365-76. PubMed ID: 26608078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
    LaPointe MC; Mendez M; Leung A; Tao Z; Yang XP
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1416-24. PubMed ID: 14670812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart.
    Meyer-Kirchrath J; Martin M; Schooss C; Jacoby C; Flögel U; Marzoll A; Fischer JW; Schrader J; Schrör K; Hohlfeld T
    Cardiovasc Res; 2009 Feb; 81(2):310-8. PubMed ID: 19019835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction.
    Xu J; Carretero OA; Lin CX; Cavasin MA; Shesely EG; Yang JJ; Reudelhuber TL; Yang XP
    Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1900-7. PubMed ID: 17586619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Cardiomyocyte α1A-Adrenergic Receptors Attenuates Postinfarct Remodeling by Inducing Angiogenesis Through Heterocellular Signaling.
    Zhao X; Balaji P; Pachon R; Beniamen DM; Vatner DE; Graham RM; Vatner SF
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2451-9. PubMed ID: 26338300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 attenuates AngII-induced cardiac hypertrophy via EP3 receptor activation and Netrin-1upregulation.
    Shen Y; Wang X; Yuan R; Pan X; Yang X; Cai J; Li Y; Yin A; Xiao Q; Ji Q; Li Y; He B; Shen L
    J Mol Cell Cardiol; 2021 Oct; 159():91-104. PubMed ID: 34147480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2-prostanoid EP3 signal induces vascular contraction via nPKC and ROCK activation in rat mesenteric artery.
    Kobayashi K; Murata T; Hori M; Ozaki H
    Eur J Pharmacol; 2011 Jun; 660(2-3):375-80. PubMed ID: 21463619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of adipocyte cyclooxygenase-2 and prostaglandin E2-prostaglandin E receptor 3 signaling in the development of obesity-induced adipose tissue inflammation and insulin resistance.
    Chan PC; Hsiao FC; Chang HM; Wabitsch M; Hsieh PS
    FASEB J; 2016 Jun; 30(6):2282-97. PubMed ID: 26932930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes.
    Hassouneh R; Nasrallah R; Zimpelmann J; Gutsol A; Eckert D; Ghossein J; Burns KD; Hébert RL
    Diabetologia; 2016 Jun; 59(6):1318-28. PubMed ID: 26995650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NFκB-mediated leucocyte recruitment after myocardial infarction.
    Wang Y; Liu J; Kong Q; Cheng H; Tu F; Yu P; Liu Y; Zhang X; Li C; Li Y; Min X; Du S; Ding Z; Liu L
    Cardiovasc Res; 2019 Jan; 115(1):154-167. PubMed ID: 29982352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.